PACT Pharma

About:

Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.

Website: http://pactpharma.com/

Top Investors: AbbVie, UpHonest Capital, Google Ventures, Invus, Foresite Capital

Description:

Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.The company's therapies help in the identification of neo-epitopes that serve as private mutations for each patient's cancer as well as creates an opportunity to engineer autologous T cells that target and kill tumors expressing these neo-antigens, enabling physicians to recognize and remove each patient's cancer cells.

Total Funding Amount:

$200M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hayward, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)pactpharma.com

Founders:

Antoni Ribas, David Baltimore, Jim Heath, Juan Jaen

Number of Employees:

101-250

Last Funding Date:

2020-01-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai